Superoxide activates mTOR-eIF4E-Bax route to induce enhanced apoptosis in leukemic cells

Apoptosis

Volumn 19, Issue 1, 2014, Pages 135-148

  Chaudhuri, Jaydeep ^a   Chowdhury, Avik Acharya ^a   Biswas, Nabendu ^a,b   Manna, Anirban ^a   Chatterjee, Saurav ^c   Mukherjee, Tulika ^c   Chaudhuri, Utpal ^d   Jaisankar, Parasuraman ^c   Bandyopadhyay, Santu ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

^b PRESIDENCY UNIVERSITY   (India)

^c Molecular Parasitology   (India)

^d MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Apoptosis; Bax; Eif4e; Mtor; Ros

Indexed keywords

CURCUMIN; INITIATION FACTOR 4E; LIPOCORTIN 5; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL XL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; XANTHINE OXIDASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; HAPLORHINI; HUMAN; HUMAN TISSUE; LEUKEMIA CELL; LEUKEMIA CELL LINE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; EUKARYOTIC INITIATION FACTOR-4E; HUMANS; K562 CELLS; LEUKEMIA; MAP KINASE SIGNALING SYSTEM; SIGNAL TRANSDUCTION; SUPEROXIDES; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84892701453     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-013-0904-9     Document Type: Article

References (48)

1. Wang J, Yi J (2008) Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 7:1875-1884
2. Mittler R, Vanderauwera S, Suzuki N, Miller G, Tognetti VB, Vandepoele K, Gollery M, Shulaev V, van Breusegem F (2011) ROS signaling: the new wave? Trends Plant Sci 16:300-309
3. Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P (2005) Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol Cell Biol 25:6391-6403
4. Zündorf G, Reiser G (2011) Calcium dysregulation and homeostasis of neural calcium in the molecular mechanisms of neurodegenerative diseases provide multiple targets for neuroprotection. Antioxid Redox Signal 14:1275-1288
5. Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, Suri KA, Qazi GN, Singh J (2007) Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-Acetyl cysteine. Apoptosis 12:2115-2133
6. Wada T, Penninger JM (2004) Mitogen-Activated protein kinases in apoptosis regulation. Oncogene 23:2349-2838
7. Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274-293
8. Ishikawa D, Takeuchi S, Nakagawa T, Sano T, Nakade J, Nanjo S, Yamada T, Ebi H, Zhao L, Yasumoto K, Nakamura T, Matsumoto K, Kagamu H, Yoshizawa H, Yano S (2013) mTOR inhibitors control the growth of EGFR mutant lung cancer even after acquiring resistance by HGF. PLoS ONE 8:e62104
9. Vignot S, Faivre S, Aguirre D, Raymond E (2005) mTOR-targeted therapy of cancer with rapamycin derivatives. Ann Oncol 16:525-537
10. Chen L, Xu B, Liu L, Luo Y, Zhou H, Chen W, Shen T, Han X, Kontos CD, Huang S (2011) Cadmium induction of reactive oxygen species activates the mTOR pathway, leading to neuronal cell death. Free Radic Biol Med 50:624-632
11. Kato H, Nakajima S, Saito Y, Takahashi S, Katoh R, Kitamura M (2012) mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathway. Cell Death Differ 19:310-320
12. Xu B, Chen S, Luo Y, Chen Z, Liu L, Zhou H, Chen W, Shen T, Han X, Chen L, Huang S (2011) Calcium signaling is involved in cadmium-induced neuronal apoptosis via induction of reactive oxygen species and activation of MAPK/mTOR network. PLoS ONE 6:e19052
13. Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N (1996) Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J 15:658-664
14. Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T, Watanabe-Fukunaga R, Fukunaga R, Teruya-Feldstein J, Pelletier J, Lowe SW (2007) Dissecting eIF4E action in tumorigenesis. Genes Dev 21:3232-3237
15. Jiang Y, Zhang SH, Han GQ, Qin CY (2010) Interaction of Pdcd4 with eIF4E inhibits the metastatic potential of hepatocellular carcinoma. Biomed Pharmacother 64:424-429
16. Shveygert M, Kaiser C, Bradrick SS, Gromeier M (2010) Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-Activated protein kinase occurs through modulation of Mnk1-eIF4G interaction. Mol Cell Biol 21:5160-5167
17. Duncan RF, Peterson H, Sevanian A (2005) Signal transduction pathways leading to increased eIF4E phosphorylation caused by oxidative stress. Free Radic Biol Med 38:631-643
18. Furic L, Rong L, Larsson O, Koumakpayi IH, Yoshida K, Brueschke A, Petroulakis E, Robichaud N, Pollak M, Gaboury LA, Pandolfi PP, Saad F, Sonenberg N (2010) eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc Natl Acad Sci USA 107:14134-14139
19. Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KL (2005) eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 30UTR. J Cell Biol 169:245-256
20. Li S, Takasu T, Perlman DM, Peterson MS, Burrichter D, Avdulov S, Bitterman PB, Polunovsky VA (2003) Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release. J Biol Chem 278:3015-3022
21. Chakraborty JB, Mahato SK, Joshi K, Shinde V, Rakshit S, Biswas N, Mukherjee IC, Mandal L, Ganguly D, Chowdhury AA, Chaudhuri J, Paul K, Pal BC, Vinayagam J, Pal C, Manna A, Jaisankar P, Chaudhuri U, Konar A, Roy S, Bandyopadhyay S (2012) Hydroxychavicol, a Piper betel leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance. Cancer Sci 103:88-99
22. Yu J, Peng Y, Wu LC, Xie Z, Deng Y, Hughes T, He S,Mo X, Chiu M, Wang QE, He X, Liu S, Grever MR, Chan KK, Liu Z (2013) Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia. PLoS ONE 8:e55934
23. Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321-334
24. Bandyopadhyay G, Biswas T, Roy KC, Mandal S, Mandal C, Pal BC, Bhattacharya S, Rakshit S, Bhattacharya DK, Chaudhuri U, Konar A, Bandyopadhyay S (2004) Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-Activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells. Blood 104:2514-2522
25. Kubonishi I, Miyoshi I (1983) Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis. Int J Cell Cloning 1:105-117
26. Friis MB, Friborg CR, Schneider L, Nielsen MB, Lambert IH, Christensen ST, Hoffmann EK (2005) Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts. J Physiol 567:427-443
27. Ravindra PV, Tiwari AK, Ratta B, Chaturvedi U, Palia SK, Subudhi PK, Kumar R, Sharma B, Rai A, Chauhan RS (2008) Induction of apoptosis in Vero cells by Newcastle disease virus requires viral replication, de novo protein synthesis and caspase activation. Virus Res 133:285-290
28. Rakshit S, Mandal L, Pal BC, Bagchi J, Biswas N, Chaudhuri J, Chowdhury AA, Manna A, Chaudhuri U, Konar A, Mukherjee T, Jaisankar P, Bandyopadhyay S (2010) Involvement of ROS in chlorogenic acid-induced apoptosis of Bcr-Abl ? CML cells. Biochem Pharmacol 80:1662-1675
29. Bharti AC, Donato N, Singh S, Aggarwal BB (2003) Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 10:1053-1062
30. Berenbaum MC (1981) Criteria for analyzing interactions between biologically active agents. Adv Cancer Res 35:269-335
31. Beevers CS, Chen L, Liu L, Luo Y, Webster NJ, Huang S (2009) Curcumin disrupts the mammalian target of rapamycin-raptor complex. Cancer Res 69:1000-1008
32. Chou TC, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzym Regul 22:27-55
33. Kim I, Xu W, Reed JC (2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 7:1013-1030
34. Lee YJ, Kim NY, Suh YA, Lee C (2011) Involvement of ROS in curcumin-induced autophagic cell death. Korean J Physiol Pharmacol 15:1-7
35. Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8:579-591
36. Wang WZ, Li L, Liu MY, Jin XB, Mao JW, Pu QH, Meng MJ, Chen XG, Zhu JY (2013) Curcumin induces FasL-related apoptosis through p38 activation in human hepatocellular carcinoma Huh7 cells. Life Sci 92:352-358
37. Chen MB, Zhang Y, Wei MX, Shen W, Wu XY, Yao C, Lu PH (2013) Activation of AMP-Activated protein kinase (AMPK) mediates plumbagin-induced apoptosis and growth inhibition in cultured human colon cancer cells. Cell Signal 25:1993-2002
38. Moreno-Manzano V, Ishikawa Y, Lucio-Cazana J, Kitamura M (2000) Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-Alpha-induced apoptosis of rat mesangial cells. J Biol Chem 275:12684-12691
39. O'Brien PJ (1991) Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 80:1-41
40. Sakano K, Inagaki Y, Oikawa S, Hiraku Y, Kawanishi S (2004) Copper-mediated oxidative DNA damage induced by eugenol: possible involvement of O-demethylation. Mutat Res 565:35-44
41. Fang J, Lu J, Holmgren A (2005) Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem 280:25284-25290
42. Atsumi T, Fujisawa S, Tonosaki K (2005) Relationship between intracellular ROS production and membrane mobility in curcumin-and tetrahydrocurcumin-treated human gingival fibroblasts and human submandibular gland carcinoma cells. Oral Dis 11:236-242
43. Silva A, G?rio A, Cebola I, Santos CI, Antunes F, Barata JT (2011) Intracellular reactive oxygen species are essential for PI3K/Akt/mTOR-dependent IL-7-mediated viability of T-cell acute lymphoblastic leukemia cells. Leukemia 25:960-967
44. Su X, Wang P, Wang X, Guo L, Li S, Liu Q (2013) Involvement of MAPK activation and ROS generation in human leukemia U937 cells undergoing apoptosis in response to sonodynamic therapy. Int J Radiat Biol. doi:10.3109/09553002. 2013.817700
45. Das F, Ghosh-Choudhury N, Bera A, Kasinath BS, Choudhury GG (2013) TGFb-induced PI 3 kinase-dependent Mnk-1 activation is necessary for Ser-209 phosphorylation of eIF4E and mesangial cell hypertrophy. J Cell Physiol. doi:10.1002/jcp. 24327
46. Graff JR, Konicek BW, Carter JH, Marcusson EG (2008) Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 68:631-634
47. Chen YJ, Tan BC, Cheng YY, Chen JS, Lee SC (2010) Differential regulation of CHOP translation by phosphorylated eIF4E under stress conditions. Nucl Acids Res 38:764-777
48. Tsukano H, Gotoh T, Endo M, Miyata K, Tazume H, Kadomatsu T, Yano M, Iwawaki T, Kohno K, Araki K, Mizuta H, Oike Y (2010) The endoplasmic reticulum stress-C/EBP homologous protein pathway-mediated apoptosis in macrophages contributes to the instability of atherosclerotic plaques. Arterioscler Thromb Vasc Biol 30:1925-1932